A detailed history of Crown Wealth Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Crown Wealth Group, LLC holds 842 shares of AMGN stock, worth $235,768. This represents 0.13% of its overall portfolio holdings.

Number of Shares
842
Previous 840 0.24%
Holding current value
$235,768
Previous $262,000 3.44%
% of portfolio
0.13%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $618 - $674
2 Added 0.24%
842 $271,000
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $2,890 - $3,512
11 Added 1.33%
840 $262,000
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $12,099 - $14,605
45 Added 5.74%
829 $235,000
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $200,468 - $226,152
784 New
784 $225,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Crown Wealth Group, LLC Portfolio

Follow Crown Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crown Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crown Wealth Group, LLC with notifications on news.